A genomic approach to therapeutic target validation identifies a glucose-lowering GLP1R variant protective for coronary heart disease. (2016)

First Author: Scott RA
Attributed to:  Further defining the genetic architecture of Alzheimer's disease funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1126/scitranslmed.aad3744

PubMed Identifier: 27252175

Publication URI: http://europepmc.org/abstract/MED/27252175

Type: Journal Article/Review

Volume: 8

Parent Publication: Science translational medicine

Issue: 341

ISSN: 1946-6234